Cartalax, 20mg

Cartalax is a cartilage-derived short peptide bioregulator from the Khavinson series with proposed tissue-specific regulatory activity in cartilaginous tissue. Research from the originating laboratory reports effects on chondrocyte signalling, collagen II synthesis, proteoglycan expression, and extracellular matrix regulation. Research applications include cartilage biology, chondrocyte function, ECM pathway investigation, and short peptide bioregulator mechanism studies. Independently third-party HPLC-tested; COA available per batch.